Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 13

TABLE OF CONTENTS Volume 37, Issue 13 (December 2012) In this issue Original Articles Obituaries Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Neuropsychopharmacology Reviews Highlighting Neurotherapeutics in 2012 Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles. Visit www.neuropsychopharmacologyreviews.org and gain access to the full list of reviews.   Original Articles Top Clozapine-Induced Locomotor Suppression is Mediated by 5-HT2A Receptors in the Forebrain Caitlin E McOmish, Alena Lira, James B Hanks and Jay A Gingrich Neuropsychopharmacology 2012 37: 2747-2755; advance online publication, August 8, 2012; 10.1038/npp.2012.139 Abstract | Full Text Seizure Susceptibility and Epileptogenesis in a Rat Model of Epilepsy and Depression Co-Morbidity S Alisha Epps, Kroshona D Tabb, Sharon J Lin, Alexa B Kahn, Martin A Javors, Katherine A Boss-Williams, Jay M Weiss and David Weinshenker Neuropsychopharmacology 2012 37: 2756-2763; advance online publication, August 8, 2012; 10.1038/npp.2012.141 Abstract | Full Text The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T 1H-MRS Study Kejia Cai, Ravi PR Nanga, Lisa Lamprou, Claudia Schinstine, Mark Elliott, Hari Hariharan, Ravinder Reddy and C Neill Epperson Neuropsychopharmacology 2012 37: 2764-2771; advance online publication, August 8, 2012; 10.1038/npp.2012.142 Abstract | Full Text Brain Activation Associated with Attentional Bias in Smokers is Modulated by a Dopamine Antagonist Maartje Luijten, Dick J Veltman, Robert Hester, Marion Smits, Lolke Pepplinkhuizen and Ingmar H A Franken Neuropsychopharmacology 2012 37: 2772-2779; advance online publication, August 1, 2012; 10.1038/npp.2012.143 Abstract | Full Text Upregulation of Nerve Growth Factor in Central Amygdala Increases Sensitivity to Opioid Reward Bihua Bie, Yan Wang, You-Qing Cai, Zhi Zhang, Yuan-Yuan Hou and Zhizhong Z Pan Neuropsychopharmacology 2012 37: 2780-2788; advance online publication, August 8, 2012; 10.1038/npp.2012.144 Abstract | Full Text Preclinical Evaluation of Reconsolidation Blockade by Clonidine as a Potential Novel Treatment for Posttraumatic Stress Disorder Karine Gamache, Roger K Pitman and Karim Nader Neuropsychopharmacology 2012 37: 2789-2796; advance online publication, August 8, 2012; 10.1038/npp.2012.145 Abstract | Full Text Differences in FKBP51 Regulation Following Chronic Social Defeat Stress Correlate with Individual Stress Sensitivity: Influence of Paroxetine Treatment Klaus V Wagner, Daria Marinescu, Jakob Hartmann, Xiao-Dong Wang, Christiana Labermaier, Sebastian H Scharf, Claudia Liebl, Manfred Uhr, Florian Holsboer, Marianne B Müller and Mathias V Schmidt Neuropsychopharmacology 2012 37: 2797-2808; advance online publication, August 8, 2012; 10.1038/npp.2012.150 Abstract | Full Text Corticotropin-Releasing Factor (CRF)-Induced Disruption of Attention in Rats Is Blocked by the κ-Opioid Receptor Antagonist JDTic Ashlee Van'T Veer, Jessica M Yano, F Ivy Carroll, Bruce M Cohen and William A Carlezon, Jr Neuropsychopharmacology 2012 37: 2809-2816; advance online publication, September 5, 2012; 10.1038/npp.2012.151 Abstract | Full Text Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice Sonia Villapol, Alexandra K Yaszemski, Trevor T Logan, Enrique Sánchez-Lemus, Juan M Saavedra and Aviva J Symes Neuropsychopharmacology 2012 37: 2817-2829; advance online publication, August 15, 2012; 10.1038/npp.2012.152 Abstract | Full Text A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites Boadie W Dunlop, Michael E Thase, Chuan-Chuan Wun, Rana Fayyad, Christine J Guico-Pabia, Jeff Musgnung and Philip T Ninan Neuropsychopharmacology 2012 37: 2830-2836; advance online publication, August 22, 2012; 10.1038/npp.2012.153 Abstract | Full Text Glycine Transporter-1 Inhibition Preceding Extinction Training Inhibits Reacquisition of Cocaine Seeking Cindy Achat-Mendes, Bríd Á Nic Dhonnchadha, Donna M Platt, Kathleen M Kantak and Roger D Spealman Neuropsychopharmacology 2012 37: 2837-2845; advance online publication, September 5, 2012; 10.1038/npp.2012.155 Abstract | Full Text The Electrophysiological Signature of Motivational Salience in Mice and Implications for Schizophrenia Carolin Moessnang, Ute Habel, Frank Schneider and Steven J Siegel Neuropsychopharmacology 2012 37: 2846-2854; advance online publication, August 22, 2012; 10.1038/npp.2012.156 Abstract | Full Text Effect of Genetic Variant in BICC1 on Functional and Structural Brain Changes in Depression Rachel Bermingham, Angela Carballedo, Danuta Lisiecka, Andrew Fagan, Derek Morris, Ciara Fahey, Gary Donohoe, James Meaney, Michael Gill and Thomas Frodl Neuropsychopharmacology 2012 37: 2855-2862; advance online publication, August 22, 2012; 10.1038/npp.2012.158 Abstract | Full Text Heroin Self-Administration Experience Establishes Control of Ventral Tegmental Glutamate Release by Stress and Environmental Stimuli Bin Wang, Zhi-Bing You and Roy A Wise Neuropsychopharmacology 2012 37: 2863-2869; advance online publication, September 5, 2012; 10.1038/npp.2012.167 Abstract | Full Text Stress-Induced Memory Retrieval Impairments: Different Time-Course Involvement of Corticosterone and Glucocorticoid Receptors in Dorsal and Ventral Hippocampus R Dorey, C Piérard, F Chauveau, V David and D Béracochéa Neuropsychopharmacology 2012 37: 2870-2880; advance online publication, September 5, 2012; 10.1038/npp.2012.170 Abstract | Full Text Obituaries Top Stephen G Holtzman Linda S Brady Neuropsychopharmacology 2012 37: 2881-2882; 10.1038/npp.2012.159 Full Text Jose Manuel Rodriguez Delgado Barry Blackwell Neuropsychopharmacology 2012 37: 2883-2884; 10.1038/npp.2012.160 Full Text Samuel C Kaim James H Woods Neuropsychopharmacology 2012 37: 2885; 10.1038/npp.2012.164 Full Text Wylie W Vale Charles B Nemeroff Neuropsychopharmacology 2012 37: 2886; 10.1038/npp.2012.165 Full Text Arthur Yuwiler Samuel Gershon and Gregory Oxenkrug Neuropsychopharmacology 2012 37: 2887; 10.1038/npp.2012.166 Full Text Edward G Jones Cameron S Carter Neuropsychopharmacology 2012 37: 2888; 10.1038/npp.2012.196 Full Text Toni S Shippenberg Antonello Bonci Neuropsychopharmacology 2012 37: 2889; 10.1038/npp.2012.199 Full Text Andrew C Leon Andrew A Nierenberg Neuropsychopharmacology 2012 37: 2890; 10.1038/npp.2012.201 Full Text Advertisement Neuropsychopharmacology Brainpod: Neurotherapeutics The brain is a daunting therapeutic challenge. This year's edition of Neuropsychopharmacology Reviews provides an update on treatments for brain disorders ranging from schizophrenia to neurodegeneration. Join Kerri Smith as she talks to Gwenn Smith, editor of this year's volume, about current therapies such as drugs, electrical stimulation and cognitive therapies, and the future of neurotherapeutics in an era of uncertain funding. Visit www.nature.com/npp/podcast   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.